Mast cells do not play a role in vitiligo
Samantha Berti(University of Florence), Silvia Moretti(University of Insubria), Romina Nassini(University of Florence), Francesca Prignano(University of Florence), Laura Castro de Amato(Azienda Sanitaria di Firenze), Adelina Spallanzani(University of Florence), Daniela Massi(University of Florence), Meena Arunachalam(Daiichi Sankyo (United States)), Roberta Colucci(University of Florence)
Cited by 5
Related Papers
4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1
|Proceedings of the National Academy of Sciences|2007|762
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
|The Lancet Oncology|2019|486
The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
|Archives of Pathology & Laboratory Medicine|2020|485
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
|British Journal of Dermatology|2012|446